Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 41


The CCR2+ Macrophage Subset Promotes Pathogenic Angiogenesis for Tumor Vascularization in Fibrotic Livers.

Bartneck M, Schrammen PL, Möckel D, Govaere O, Liepelt A, Krenkel O, Ergen C, McCain MV, Eulberg D, Luedde T, Trautwein C, Kiessling F, Reeves H, Lammers T, Tacke F.

Cell Mol Gastroenterol Hepatol. 2019;7(2):371-390. doi: 10.1016/j.jcmgh.2018.10.007. Epub 2018 Oct 18.


Effects of Platycodin D on S100A8/A9-induced inflammatory response in murine mammary carcinoma 4T1 cells.

Ye Y, Pei L, Ding J, Wu C, Sun C, Liu S.

Int Immunopharmacol. 2019 Feb;67:239-247. doi: 10.1016/j.intimp.2018.12.008. Epub 2018 Dec 15.


Circulating tumor cells promote the metastatic colonization of disseminated carcinoma cells by inducing systemic inflammation.

Li YC, Zou JM, Luo C, Shu Y, Luo J, Qin J, Wang Y, Li D, Wang SS, Chi G, Guo F, Zhang GM, Feng ZH.

Oncotarget. 2017 Apr 25;8(17):28418-28430. doi: 10.18632/oncotarget.16084.


Tumor-infiltrating monocytes/macrophages promote tumor invasion and migration by upregulating S100A8 and S100A9 expression in cancer cells.

Lim SY, Yuzhalin AE, Gordon-Weeks AN, Muschel RJ.

Oncogene. 2016 Nov 3;35(44):5735-5745. doi: 10.1038/onc.2016.107. Epub 2016 Apr 18.


The value of calprotectin S100A8/A9 complex as a biomarker in colorectal cancer: A systematic review.

Moris D, Spartalis E, Angelou A, Margonis GA, Papalambros A, Petrou A, Athanasiou A, Schizas D, Dimitroulis D, Felekouras E.

J BUON. 2016 Jul-Aug;21(4):859-866. Review.


Discovery of a Good Responder Subtype of Esophageal Squamous Cell Carcinoma with Cytotoxic T-Lymphocyte Signatures Activated by Chemoradiotherapy.

Tanaka Y, Aoyagi K, Minashi K, Komatsuzaki R, Komatsu M, Chiwaki F, Tamaoki M, Nishimura T, Takahashi N, Oda I, Tachimori Y, Arao T, Nishio K, Kitano S, Narumi K, Aoki K, Fujii S, Ochiai A, Yoshida T, Muto M, Yamada Y, Sasaki H.

PLoS One. 2015 Dec 1;10(12):e0143804. doi: 10.1371/journal.pone.0143804. eCollection 2015.


S100A9 expressed in ER(-)PgR(-) breast cancers induces inflammatory cytokines and is associated with an impaired overall survival.

Bergenfelz C, Gaber A, Allaoui R, Mehmeti M, Jirström K, Leanderson T, Leandersson K.

Br J Cancer. 2015 Oct 20;113(8):1234-43. doi: 10.1038/bjc.2015.346. Epub 2015 Oct 8.


A pro-tumorigenic function of S100A8/A9 in carcinogen-induced hepatocellular carcinoma.

De Ponti A, Wiechert L, Schneller D, Pusterla T, Longerich T, Hogg N, Vogel A, Schirmacher P, Hess J, Angel P.

Cancer Lett. 2015 Dec 28;369(2):396-404. doi: 10.1016/j.canlet.2015.09.005. Epub 2015 Sep 21.


Role of Tumor Pericytes in the Recruitment of Myeloid-Derived Suppressor Cells.

Hong J, Tobin NP, Rundqvist H, Li T, Lavergne M, García-Ibáñez Y, Qin H, Paulsson J, Zeitelhofer M, Adzemovic MZ, Nilsson I, Roswall P, Hartman J, Johnson RS, Östman A, Bergh J, Poljakovic M, Genové G.

J Natl Cancer Inst. 2015 Aug 21;107(10). pii: djv209. doi: 10.1093/jnci/djv209. Print 2015 Oct. Erratum in: J Natl Cancer Inst. 2016 Mar;108(3). pii: djv434. doi: 10.1093/jnci/djv434.


Eritoran inhibits S100A8-mediated TLR4/MD-2 activation and tumor growth by changing the immune microenvironment.

Deguchi A, Tomita T, Ohto U, Takemura K, Kitao A, Akashi-Takamura S, Miyake K, Maru Y.

Oncogene. 2016 Mar 17;35(11):1445-56. doi: 10.1038/onc.2015.211. Epub 2015 Jul 13.


In-depth LC-MS/MS analysis of the chicken ovarian cancer proteome reveals conserved and novel differentially regulated proteins in humans.

Nepomuceno AI, Shao H, Jing K, Ma Y, Petitte JN, Idowu MO, Muddiman DC, Fang X, Hawkridge AM.

Anal Bioanal Chem. 2015 Sep;407(22):6851-63. doi: 10.1007/s00216-015-8862-4. Epub 2015 Jul 10.


S100A9 promotes human hepatocellular carcinoma cell growth and invasion through RAGE-mediated ERK1/2 and p38 MAPK pathways.

Wu R, Duan L, Cui F, Cao J, Xiang Y, Tang Y, Zhou L.

Exp Cell Res. 2015 Jun 10;334(2):228-38. doi: 10.1016/j.yexcr.2015.04.008. Epub 2015 Apr 20.


NFκB1 is a suppressor of neutrophil-driven hepatocellular carcinoma.

Wilson CL, Jurk D, Fullard N, Banks P, Page A, Luli S, Elsharkawy AM, Gieling RG, Chakraborty JB, Fox C, Richardson C, Callaghan K, Blair GE, Fox N, Lagnado A, Passos JF, Moore AJ, Smith GR, Tiniakos DG, Mann J, Oakley F, Mann DA.

Nat Commun. 2015 Apr 16;6:6818. doi: 10.1038/ncomms7818. Erratum in: Nat Commun. 2015;6:8411.


Optical in vivo imaging of the alarmin S100A9 in tumor lesions allows for estimation of the individual malignant potential by evaluation of tumor-host cell interaction.

Becker A, Große Hokamp N, Zenker S, Flores-Borja F, Barzcyk K, Varga G, Roth J, Geyer C, Heindel W, Bremer C, Vogl T, Eisenblaetter M.

J Nucl Med. 2015 Mar;56(3):450-6. doi: 10.2967/jnumed.114.146688. Epub 2015 Feb 12.


Programmed cell death 6 interacting protein (PDCD6IP) and Rabenosyn-5 (ZFYVE20) are potential urinary biomarkers for upper gastrointestinal cancer.

Husi H, Skipworth RJ, Cronshaw A, Stephens NA, Wackerhage H, Greig C, Fearon KC, Ross JA.

Proteomics Clin Appl. 2015 Jun;9(5-6):586-96. doi: 10.1002/prca.201400111. Epub 2015 May 8.


The lack of type I interferon induces neutrophil-mediated pre-metastatic niche formation in the mouse lung.

Wu CF, Andzinski L, Kasnitz N, Kröger A, Klawonn F, Lienenklaus S, Weiss S, Jablonska J.

Int J Cancer. 2015 Aug 15;137(4):837-47. doi: 10.1002/ijc.29444. Epub 2015 Feb 5.


Tasquinimod modulates suppressive myeloid cells and enhances cancer immunotherapies in murine models.

Shen L, Sundstedt A, Ciesielski M, Miles KM, Celander M, Adelaiye R, Orillion A, Ciamporcero E, Ramakrishnan S, Ellis L, Fenstermaker R, Abrams SI, Eriksson H, Leanderson T, Olsson A, Pili R.

Cancer Immunol Res. 2015 Feb;3(2):136-48. doi: 10.1158/2326-6066.CIR-14-0036. Epub 2014 Nov 4.


Chronic liver inflammation and hepatocellular carcinogenesis are independent of S100A9.

De Ponti A, Wiechert L, Stojanovic A, Longerich T, Marhenke S, Hogg N, Vogel A, Cerwenka A, Schirmacher P, Hess J, Angel P.

Int J Cancer. 2015 May 15;136(10):2458-63. doi: 10.1002/ijc.29282. Epub 2014 Nov 13.


High S100A8 and S100A12 protein expression is a favorable prognostic factor for survival of oropharyngeal squamous cell carcinoma.

Funk S, Mark R, Bayo P, Flechtenmacher C, Grabe N, Angel P, Plinkert PK, Hess J.

Int J Cancer. 2015 May 1;136(9):2037-46. doi: 10.1002/ijc.29262. Epub 2014 Oct 24.


Cancer-associated adipose tissue promotes breast cancer progression by paracrine oncostatin M and Jak/STAT3 signaling.

Lapeire L, Hendrix A, Lambein K, Van Bockstal M, Braems G, Van Den Broecke R, Limame R, Mestdagh P, Vandesompele J, Vanhove C, Maynard D, Lehuédé C, Muller C, Valet P, Gespach CP, Bracke M, Cocquyt V, Denys H, De Wever O.

Cancer Res. 2014 Dec 1;74(23):6806-19. doi: 10.1158/0008-5472.CAN-14-0160. Epub 2014 Sep 24.

Supplemental Content

Loading ...
Support Center